CenturyLink, Inc. (NYSE:CTL) shares fell -0.25% in last trading session and ended the day at $31.62. CTL Gross Margin is 56.60% and its has a return on assets of 1.80%. CenturyLink, Inc. (NYSE:CTL) quarterly performance is 28.15%.
CenturyLink, Inc. (NYSE:CTL) to sell $1 bln of newly-issued unsecured eight-year senior notes.The senior notes due 2024 were priced at par with an annual coupon rate of 7.5%. The sale of these notes is expected to be completed April 6, 2016, subject to customary closing conditions. CenturyLink intends to use the net proceeds from this offering, together with additional borrowings under its revolving credit facility and available cash, if any, to provide the total amount of funds required to fully retire at maturity on June 1, 2016 all $1.184 billion aggregate principal amount of 7.082% Notes issued by its wholly-owned subsidiary, Embarq Corporation.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) ended the last trading day at $7.85. Company weekly volatility is calculated as 6.06% and price to cash ratio as 3.48. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) showed a weekly performance of 20.03%.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced its dMAb antibody and DNA vaccine targeting the chikungunya virus provided 100% protection against a lethal virus challenge in mice. InovioPharma said, while conventional vaccine and marketed monoclonal antibody technologies have shown limited ability to provide an effective solution to chikungunya virus to date, Inovio’s DNA vaccine and dMAb products show potential, separately and in combination, to offer immediate and long term protection to large populations from chikungunya virus infection.
ArQule Inc. (NASDAQ:ARQL) and Daiichi Sankyo announced that the independent data monitoring committee or DMC of the METIV-HCC study conducted the planned interim assessment and it was determined the trial will continue to its final analysis.METIV-HCC is a biomarker-selected, double-blind, placebo-controlled, pivotal phase 3 study evaluating tivantinib (2:1) versus best supportive care in previously systemically-treated patients with MET-high, inoperable HCC, with overall survival as the primary endpoint.
On 22 March, ArQule Inc. (NASDAQ:ARQL) shares moved up 13.07% and was closed at $1.73. ARQL EPS growth in last 5 year was 20.20%. ArQule Inc. (NASDAQ:ARQL) year to date (YTD) performance is -20.28%.
Allot Communications Ltd. (NASDAQ:ALLT) shares moved up 6.63% in last trading session and ended the day at $5.31. Allot Communications Ltd. (NASDAQ:ALLT) quarterly performance is -8.92%.
Allot Communications Ltd. (NASDAQ:ALLT) on March 16, announced that a leading communication service provider (CSP) in Latin America providing fixed, mobile and TV cable services, is using Allot WebSafe Business to power its network-based Security-as-a-Service (SECaaS) offerings to thousands of businesses across the region.
Western Digital Corporation (NASDAQ:WDC) caters to the Technology space. It has a net profit margin of 8.50% and weekly performance is 12.56%. On the last day of trading company shares ended up at $51.34. Western Digital Corporation (NASDAQ:WDC) distance from 50-day simple moving average (SMA50) is 38.07%.
Helping the world harness the power of data, Western Digital Corporation (NASDAQ:WDC)announced that Revera, New Zealand’s leading cloud services provider, has installed the HGST (@HGSTstorage) Active Archive System as its cloud-scale data repository for Revera Vault. Geared for deployments of all sizes – from terabytes to zettabytes, Vault relies on the HGST Active Archive System for its object store capability, capacity scaling, and unmatched data durability to optimize data accessibility and business continuity.
Leave a Reply